Xcaliber International Receives 15 Additional Orders from the FDA with Cozen O'Connor’s Guidance

Tuesday, September 11, 2018

Pryor, Oklahoma – September 11, 2018 – Cozen O'Connor guided Xcaliber International, Ltd., L.L.C. (Xcaliber), a Pryor, Okla., based cigarette manufacturer, as the organization received 15 additional orders from the U.S. Food and Drug Administration, Center for Tobacco Products (FDA) finding certain tobacco products that it manufactures to be "substantially equivalent" within the meaning of the 2009 Family Smoking Prevention and Tobacco Control Act.

Cozen O'Connor represented Xcaliber for the past three years working to obtain the 15 SE orders. In total Xcaliber has received a total of 36 orders from the FDA finding its products to be substantially equivalent to those on the market in February 2007.

Xcaliber is the largest, exclusively focused Fourth Tier deep discount manufacturer in the United States. Xcaliber is built on a foundation of providing the highest value products in the Tier Four category.

Blake Rutherford, a member of the firm’s Government and Regulatory Practice, Ryan Blaney, a member in firm’s Health Law Practice, and Alison Wils, a health policy adviser in the firm’s Public Strategies, represented Xcaliber through this unprecedented result.

About Cozen O’Connor

Established in 1970, Cozen O’Connor has more than 825 attorneys who help clients manage risk and make better business decisions. The firm counsels clients on their most sophisticated legal matters in all areas of the law, including litigation, corporate, and regulatory law. Representing a broad array of leading global corporations and middle market companies, Cozen O’Connor services its clients’ needs through 31 offices across two continents.

# # #

Related Practice Areas

Keep up-to-date with the latest news from Cozen O'Connor

Enter your City or Zip.

Probably shouldn't change this:
Sign up to receive alerts, publications, and event / webinar invites.

By submitting your contact information, you are giving Cozen O'Connor consent to contact you via email.